File(s) stored somewhere else
Please note: Linked content is NOT stored on Macquarie University and we can't guarantee its availability, quality, security or accept any liability.
Alzheimer’s disease: Ablating single master site abolishes tau hyperphosphorylation
datasetposted on 2022-06-11, 04:27 authored by Kristie Stefanoska, Arne Ittner, Mehul Gajwani, Amanda RP Tan, Holly Ahel, Prita Asih, Alexander Volkerling, Anne Poljak
Hyper-phosphorylation of the neuronal tau protein is a hallmark of neurodegenerative tauopathies like Alzheimer’s disease. A central unanswered question is why tau becomes progressively hyper-phosphorylated. Here, we show that tau phosphorylation is governed by interdependence - a mechanistic link between initial site-specific and subsequent multi-site phosphorylation. Systematic assessment of site interdependence identified distinct residues (Threonine-50, -69, -181) as master sites that determine propagation of phosphorylation at multiple epitopes. CRISPR point mutation and expression of human tau in Alzheimer’s mice showed that site interdependence governs physiologic and amyloid-associated multi-site phosphorylation and cognitive deficits, respectively. Combined targeting of master sites and p38α, the most central tau kinase linked to interdependence, synergistically ablated hyper-phosphorylation. In summary, our work delineates how complex tau phosphorylation arises to inform therapeutic and biomarker design for tauopathies.
MethodsRaw Immunoblot data for Figure 1. Chemiluninescence signals were imaged on a ChemiDoc MP (Biorad) digital system.
Australian Research Council : DP200102396
National Health and Medical Research Council : 1143978
Australian Research Council : DP170100843
National Health and Medical Research Council : 1176628
Dementia Australia Research Foundation
Australian Research Council : DP220101900
FAIR Self Assessment Rating